We recently compiled a list of the 10 Best Weight Loss Drug Stocks to Buy in 2026. Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best weight loss drugs on this list. TheFly reported ...

Austedo (deutetrabenazine) is a prescription drug used to treat involuntary movements caused by certain conditions. Austedo can interact with alcohol, other drugs, and some supplements. For example, ...

With a short percentage of shares outstanding of 2.91%, Teva Pharmaceutical Industries Limited (NYSE:TEVA) is among the 7 ...

In a recent survey, doctors said they expect Teva's Austedo to capture 45% of the tardive dyskinesia market at its peak. (Teva) () In the brand-new tardive dyskinesia market, doctors initially ...

Austedo and Austedo XR are prescribed to treat chorea related to Huntington’s disease and tardive dyskinesia in adults. They can cause side effects ranging from mild, such as drowsiness and insomnia, ...

Teva's first DTC ad for Austedo tells people with involuntary movements that "It's not OK" and encourages talking to their doctors. (Teva) () Teva's first DTC campaign for tardive dyskinesia (TD) drug ...

PARSIPPANY, N.J., and TEL AVIV, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the ...

Add Yahoo as a preferred source to see more of our stories on Google. The logo of Teva Pharmaceutical Industries is seen during a news conference in Tel Aviv (Reuters) -Teva Pharmaceutical Industries' ...

Teva has been building its comeback, and the latest studies on Austedo and Austedo XR will help further that momentum.

PARSIPPANY, N.J. and TEL AVIV, Israel, June 08, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data ...

(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), said that the U.S. Food and Drug Administration has approved AUSTEDO XR as a one pill, once-daily ...

In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO ...